18th Annual Outsourcing in Clinical Trials West Coast 2026

About the Event Detail Information Event 18th Annual Outsourcing in Clinical Trials West Coast 2026 Dates February 11 , February 12, 2026 Venue Hyatt Regency San Francisco Airport Address 1333 Old Bayshore Highway City Burlingame State / Region California Country United States Event Type B2B Clinical Trials Conference , Outsourcing Conference , Pharma Biotech Partnering Event Primary Category Medical & Pharma Secondary Categories Science & Research , IT & Technology , Business Services Audience Reach National , Global Attendance 400+ attendees , nearly 450 expected Exhibitors 30+ Speakers 30+ Director+ audience 80% Arena International advertised 400+ attendees , 30+ exhibitors , 30+ speakers , 80% of attendees at Director level or above. Parexel separately described the event as expecting nearly 450 attendees. 1️⃣ Who Attends, BUYERS / ATTENDEES This is primarily a clinical development and outsourcing decision-maker event, not a broad medical conference. The highest-value buyer audience is: Pharmaceutical Companies , Biotechnology Companies , Biopharmaceutical Companies , Medical Device Companies , Clinical-Stage Biotechs , Emerging Biotechs , Drug Development Companies The organizer's complimentary-pass policy is revealing: free passes were specifically restricted to operational titles at biotech , pharma , device companies with active clinical pipelines, while service providers and business-development vendors were excluded from that category. That is a powerful signal that the attendee base is intentionally sponsor-heavy. Actual buyer functions Clinical Operations , Clinical Development , Clinical Outsourcing , Vendor Management , Strategic Outsourcing , Clinical Business Operations , Regulatory Affairs , Clinical Systems , Trial Management , Clinical Data , Biomarkers , Patient Engagement , Clinical Innovation 2️⃣ Where Attendees Come From Event location Burlingame , San Francisco Bay Area , California , United States Strongest attendee geography Because of the density of biotech and pharma companies in California, the strongest buyer markets are: San Francisco Bay Area , South San Francisco , San Mateo , Burlingame , Redwood City , Foster City , Menlo Park , Palo Alto , Berkeley , Emeryville , San Diego , Los Angeles Wider US markets Boston , Cambridge , New York , New Jersey , Pennsylvania , North Carolina , Maryland , Washington , Massachusetts International participation The conference also draws global CROs, technology companies and clinical-development organizations, so additional attendee origin includes: United Kingdom , Switzerland , Germany , France , Canada , Europe , Asia Reach National , Global But for buyer-list building, California biotech should be your first hunting ground. 3️⃣ Main Buyer Groups Tier 1, Sponsor-Side Clinical Operations These are probably the most valuable attendees. VP Clinical Operations , Head of Clinical Operations , Senior Director Clinical Operations , Director Clinical Operations , Associate Director Clinical Operations , Clinical Trial Director , Clinical Program Director They buy: CRO services , FSP services , clinical technology , patient recruitment , trial logistics , clinical staffing , eCOA , eConsent , CTMS , eTMF , data solutions Tier 2, Outsourcing & Vendor Management Head of Clinical Outsourcing , Clinical Outsourcing Director , Strategic Outsourcing Director , Vendor Management Director , Clinical Contracts Director , Clinical Business Operations Director These people are extremely high-value because vendor selection is literally their job. Tier 3, Clinical Development Leadership Chief Medical Officer , Head of Clinical Development , VP Clinical Development , Development Lead , Clinical Development Director Tier 4, Regulatory VP Regulatory Affairs , Head of Regulatory Affairs , Regulatory Affairs Director , Global Regulatory Affairs Director Tier 5, Technology & Clinical Systems Head of Clinical Systems , Clinical Systems Director , Clinical Technology Director , Digital Clinical Operations Director , Clinical Data Director 4️⃣ Confirmed / Evidenced Buyer-Side Companies The 2026 agenda contains a strong collection of actual pharma and biotech companies. Examples include: TORL Biotherapeutics , Sardocor , Adjuvia Therapeutics , Aerys Biosciences , Allay Therapeutics , Alumis , Amgen , Apogee Therapeutics , Biomea Fusion , Cytokinetics , Calico Life Sciences , Andarix , Avidity Biosciences , Kamau Therapeutics , Exelixis , Ultragenyx , Ascendis Pharma The published 2026 agenda names executives from these companies in clinical development, operations, outsourcing, regulatory and technology roles. Strong buyer examples Buyer Company Why Relevant Website TORL Biotherapeutics Clinical-stage biotech , development buyer torlbiotherapeutics.com Sardocor Clinical operations buyer sardocor.com Alumis Clinical-stage biotech alumis.com Amgen Large biopharma clinical-development buyer amgen.com Apogee Therapeutics Clinical-stage biotech , clinical systems apogeetherapeutics.com Biomea Fusion Oncology biotech , regulatory / clinical development biomeafusion.com Cytokinetics Biopharma , clinical outsourcing cytokinetics.com Calico Life Sciences Drug-development company , clinical contracts calicolabs.com Exelixis Oncology biopharma , strategic outsourcing exelixis.com Ultragenyx Rare disease biopharma ultragenyx.com Ascendis Pharma Biopharma , clinical business operations ascendispharma.com Avidity Biosciences Clinical-stage biotech , AI / analytics aviditybiosciences.com These are much stronger targets than CRO exhibitors if your client is selling services to sponsors. 5️⃣ Specific High-Value Buyer Roles Seen at the Event The 2026 material includes roles such as: Senior Vice President Development Lead , Vice President Clinical Operations , Vice President Global Regulatory Affairs , Head of Clinical Outsourcing and Contract Management , Senior Director Head of Clinical Systems and Trial Master File , Director Biomarker Operations , Clinical Contracts , Associate Director Clinical Operations For example: Gajanan Bhat , Senior Vice President Development Lead , TORL Biotherapeutics Niharika Kamat , Vice President Clinical Operations , Sardocor Hanna Cho , Vice President Global Regulatory Affairs , Biomea Fusion Jasmine Washington , Head of Clinical Outsourcing and Contract Management , Cytokinetics Alexander Markiel , Senior Director Head of Clinical Systems and Trial Master File , Apogee Therapeutics This is exactly the kind of audience clinical-service vendors dream about. 6️⃣ Vendors Versus Buyers This distinction is crucial. Companies such as: ICON Biotech , Parexel , World Courier , mdgroup , SimpleTrials , Thermo Fisher Scientific , Caidya appeared as sponsors, exhibitors or service providers. For a buyer-only database, do not mix them indiscriminately with sponsor-side pharma companies. Buyers Pharma , Biotech , Medical Device Sponsors Sellers / Service Providers CROs , FSPs , Patient Recruitment Companies , Clinical Technology Vendors , Logistics Providers , Consulting Firms Unless your client sells to CROs, these should usually be excluded from the primary buyer list. 7️⃣ Estimated Attendance Best supported numbers: 400+ attendees Parexel's event page said: Nearly 450 attendees expected Arena International stated: 400+ attendees , 30+ exhibitors , 30+ speakers , 80% Director+ Recommended working attendance 400 , 450 total attendees This is a relatively small event, but the attendee seniority is the jewel in the crown. 8️⃣ Decision-Maker Quality 80% Director level or above That makes OCT West Coast substantially more targeted than a huge general pharma expo. Buyer quality Clinical decision-maker concentration: 10/10 Sponsor-company relevance: 10/10 Outsourcing buyer quality: 10/10 Biotech relevance: 10/10 Pharma relevance: 9/10 Medical device relevance: 7/10 Overall attendee-list quality: 9.5/10 This is small-volume, high-potency data. More espresso shot than swimming pool. ☕ 9️⃣ Key Event Focus Areas The 2026 conference used these principal streams: Outsourcing & Clinical Operations , AI and Tech Transformation , Patient Centricity , Biotech Strategy Commercial focus areas include: CRO selection , vendor oversight , clinical outsourcing , FSP models , clinical operations , trial execution , clinical technology , AI in clinical trials , trial master file , regulatory strategy , patient engagement , decentralized trials , clinical data , vendor management , biotech development strategy 🔟 What Buyers Are Purchasing Depending on role, attendees may be sourcing: Contract Research Organizations , CRO Services , FSP Services , Clinical Monitoring , Project Management , Trial Management , Clinical Staffing , Patient Recruitment , Patient Engagement , CTMS , eTMF , EDC , eCOA , eConsent , IRT , RTSM , Clinical Data Management , Biomarker Services , Imaging , Medical Writing , Regulatory Services , Trial Logistics , Home Health Services , Site Services , Decentralized Trial Solutions The entire premise of the event is finding outsourcing partners and solutions for clinical trial execution. 1️⃣1️⃣ Best Apollo Industries Using only your Apollo industry list: Tier 1 Biotechnology , Pharmaceuticals , Medical Devices Tier 2 Hospital & Health Care , Research , Information Technology & Services , Computer Software For pure sponsor targeting Use: Biotechnology , Pharmaceuticals , Medical Devices That is the cleanest filter. Apollo Industry String Biotechnology , Pharmaceuticals , Medical Devices , Research , Hospital & Health Care For clinical outsourcing buyers specifically, I would start with only: Biotechnology , Pharmaceuticals , Medical Devices 1️⃣2️⃣ Best Apollo Job Titles Highest Priority Vice President Clinical Operations , VP Clinical Operations , Head of Clinical Operations , Senior Director Clinical Operations , Director Clinical Operations , Clinical Operations Director , Head of Clinical Outsourcing , Director Clinical Outsourcing , Clinical Outsourcing Director , Head of Clinical Business Operations , Director Clinical Business Operations Strategic Vendor Buyers Head of Strategic Outsourcing , Strategic Outsourcing Director , Vendor Management Director , Head of Vendor Management , Clinical Contracts Director , Clinical Procurement Director Development Leadership Chief Medical Officer , VP Clinical Development , Head of Clinical Development , Clinical Development Director , Development Lead Clinical Systems Head of Clinical Systems , Director Clinical Systems , Clinical Technology Director , Head of Clinical Technology , Clinical Data Director Apollo Job Title String VP Clinical Operations , Vice President Clinical Operations , Head of Clinical Operations , Senior Director Clinical Operations , Director Clinical Operations , Clinical Operations Director , Head of Clinical Outsourcing , Director Clinical Outsourcing , Clinical Outsourcing Director , Head of Clinical Business Operations , Director Clinical Business Operations , Strategic Outsourcing Director , Head of Strategic Outsourcing , Vendor Management Director , Head of Vendor Management , Clinical Contracts Director , VP Clinical Development , Head of Clinical Development , Clinical Development Director , Chief Medical Officer , Head of Clinical Systems , Director Clinical Systems 1️⃣3️⃣ Apollo Keywords clinical stage biotech , clinical trials , clinical development , clinical operations , drug development , biopharmaceutical , clinical research , clinical pipeline , oncology biotech , rare disease biotech , therapeutic development , clinical outsourcing , clinical trial sponsor 1️⃣4️⃣ Best Company Stage Filter For clinical outsourcing vendors, target companies with: Phase I pipeline , Phase II pipeline , Phase III pipeline , active IND , clinical-stage assets Company types: Clinical-Stage Biotechnology , Emerging Biopharma , Mid-Sized Biopharma , Pharmaceutical Companies Ideal employee size For CRO and service-provider campaigns: 11-50 , 51-200 , 201-500 , 501-1,000 The sweet spot is often: 51-200 , 201-500 because these biotechs frequently lack enough internal resources and outsource heavily. Large pharma: 1,001-5,000 , 5,001-10,000 , 10,000+ can also spend heavily but generally have more formal supplier frameworks. 1️⃣5️⃣ Best Buyer Segments Segment A, Emerging Biotech Clinical-stage biotechnology companies , venture-backed biotech , oncology biotech , rare disease biotech Titles: VP Clinical Operations , Head of Clinical Operations , COO , Chief Medical Officer , Clinical Development Director This is arguably the highest-value segment. Segment B, Mid-Sized Biopharma Titles: Clinical Outsourcing Director , Strategic Outsourcing Director , Vendor Management Director , Clinical Operations Director Segment C, Large Pharma Titles: Head of Clinical Outsourcing , Procurement Director , Vendor Strategy Director , Clinical Operations Director Segment D, Medical Device Sponsors Titles: VP Clinical Affairs , Director Clinical Affairs , Clinical Operations Director , Regulatory Affairs Director 1️⃣6️⃣ Sample High-Priority Buyer Accounts Based on the actual 2026 speaker and agenda ecosystem: TORL Biotherapeutics , Sardocor , Alumis , Amgen , Apogee Therapeutics , Biomea Fusion , Cytokinetics , Calico Life Sciences , Avidity Biosciences , Exelixis , Ultragenyx , Ascendis Pharma , Adjuvia Therapeutics , Allay Therapeutics , Aerys Biosciences , Andarix These are the companies I would investigate first when constructing a sponsor-side buyer list. 1️⃣7️⃣ Buyer Engagement The event is structured around: One-to-one networking , CRO evaluation , vendor discussions , outsourcing strategy , technology demonstrations , supplier comparison , clinical partnership meetings , sponsor-vendor discussions , regulatory discussions , operational benchmarking Exhibitor engagement is actively encouraged through networking breaks and exhibition-hall activity. ⭐ Recommended Apollo Setup Industries Biotechnology , Pharmaceuticals , Medical Devices Geography California , Massachusetts , New Jersey , New York , Pennsylvania , North Carolina , Maryland , Washington California sub-regions: South San Francisco , San Francisco , San Mateo , Redwood City , Foster City , Menlo Park , Palo Alto , Berkeley , Emeryville , San Diego Titles VP Clinical Operations , Head of Clinical Operations , Senior Director Clinical Operations , Director Clinical Operations , Head of Clinical Outsourcing , Clinical Outsourcing Director , Head of Strategic Outsourcing , Strategic Outsourcing Director , Vendor Management Director , Director Clinical Business Operations , VP Clinical Development , Head of Clinical Development , Chief Medical Officer Keywords clinical stage biotech , clinical development , clinical operations , clinical trials , drug development , clinical outsourcing , active clinical pipeline Company size 51-200 , 201-500 , 501-1,000 🎯 Best overall buyer profile For a generic OCT West Coast attendee database, I would prioritize: Clinical-Stage Biotechnology Companies , Biopharmaceutical Companies , Pharmaceutical Sponsors , Medical Device Sponsors and the people: VP Clinical Operations , Head of Clinical Operations , Director Clinical Operations , Head of Clinical Outsourcing , Strategic Outsourcing Director , Vendor Management Director , Clinical Business Operations Director , Chief Medical Officer Client-specific buyer matching Send me your client's website. For this event, client-product matching changes the target dramatically. A CRO, patient recruitment provider, eClinical software company, clinical logistics provider, medical imaging vendor, and staffing company should each target different sponsor-side people. Once I review the website, I can give you: Best buyer companies , company websites , Apollo industries , exact job titles , keywords , employee-size filters , clinical-stage filters , geographic filters , buyer priority tiers , CROs and vendors to exclude.